Monthly Archives: August 2014

LGMD2I zebrafish characterization and drug screening

Dr. Louis Kunkel Boston Children’s Hospital (Boston, MA)   Project Summary: Zebrafish are good model systems to study human diseases and perform drug screening (cheaper and faster than mice). This grant will support the characterization and study of the FKRP zebrafish model. The zebrafish model containing FKRP mutations that mimic the human disease will be […]

Biomarkers discovery in LGMD2I

Drs. Sebahattin Cirak and Yetrib Hathout Children’s National Medical Center (Washington, DC)   Project Summary: Surrogate biomarkers are needed to predict clinical and biochemical outcomes to guide clinical trials and monitor treatment. This project will analyze plasma samples from LGMD2I patients and compare them with samples from patients with other sub-types of dystroglycanopathies and with […]

Stem Cell therapy in mouse model of LGMD2I

Drs. Casey Childers & David Mack University of Washington (Seattle, WA)   Project Summary: The objective of this project is to test the efficacy of stem cell therapy in improving muscle function of the mouse model of LGMD2I. Induced Pluripotent Stem (iPS) cells derived from normal control mice will be induced to become muscle progenitor […]

Assessment of Muscle Function in mouse model of LGMD2I

Dr. Dan Rodgers Washington State University (Pullman, WA)   Project Summary: The objective of this project is to characterize exercise and cardiac performance as well as muscle contractile properties of the FKRP P448L mutant mouse model. These studies will establish functional baselines for assessing drug efficacy and disease pathology in this mouse model that can […]